Abstract:RATIONALE:Endothelial dysfunction results in sustained and chronic vascular inflammation, which is central to atherosclerotic diseases. However, transcriptional regulation of vascular endothelial inflammation has not been well clarified.OBJECTIVE:This study aims to explore Foxp (forkhead box P) transcription factor 1 in regulation of endothelial homeostasis, atherogenesis, and its mechanisms.METHODS AND RESULTS:To assess the importance of Foxp1 in atherosclerosis, Foxp1 expression was analyzed in human coronary artery and mouse artery, and we observed significant downregulation of Foxp1 in atherosclerotic and atherosusceptible endothelium. Endothelial-specific Foxp1 knockout mice (Foxp1ECKO) were bred onto ApoeKO mice to generate endothelial Foxp1-deletion hyperlipidemic model Foxp1ECKO;ApoeKO, which displayed significant increases in atherosclerotic lesion formation in aortas and aortic roots with enhanced monocyte adhesion, migration, and infiltration into the vascular wall and formation of inflammatory lipid-laden macrophages. In contrast, endothelial-specific Foxp1 overexpression mice Foxp1ECTg;ApoeKO exhibited reduced atherosclerotic lesion formation with less monocyte infiltration. Foxp1 was further identified as a gatekeeper of vessel inflammation by direct regulation of endothelial inflammasome components, including Nlrp3 (NLR [nucleotide-binding and leucine-rich repeat immune receptors] family pyrin domain containing 3), caspase-1, and IL (interleukin)-1β. Moreover, endothelial Foxp1 was found to be regulated by Klf2 (Kruppel-like factor 2). Oscillatory shear stress downregulated Foxp1 expression via repressing Klf2 expression in endothelium, and, therefore, promoted endothelial inflammasome activation, leading to atherosclerotic lesion formation. Simvastatin upregulated the reduced expression of Klf2 and Foxp1 in atherosusceptible vascular endothelium and alleviated vascular inflammation contributing to its inhibitory effect in atherosclerosis.CONCLUSIONS:These data are the first in vivo experimental validation of an atheroprotective role of endothelial Klf2 and Foxp1, which reveals a Klf2-Foxp1 transcriptional network in endothelial cells as a novel regulator of endothelial inflammasome activation for atherogenesis, therefore, provides opportunities for therapeutic intervention of atherosclerotic diseases and uncovers a novel atheroprotective mechanism for simvastatin.

Endothelial NLRP3 inflammasome regulation in atherosclerosis

Endothelial Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Inflammasome Regulation in Atherosclerosis.

Hypoxia activates macrophage-NLRP3 inflammasome promoting atherosclerosis via PFKFB3-driven glycolysis

Endothelial Foxp1 Suppresses Atherosclerosis Via Modulation of Nlrp3 Inflammasome Activation.

Activation of NLRP3 Inflammasome Promotes Foam Cell Formation in Vascular Smooth Muscle Cells and Atherogenesis Via HMGB1.

Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility

Nlrp3 Activation In Endothelia Promotes Development Of Diabetes-Associated Atherosclerosis

PFKFB3 Promotes Endotoxemia-Induced Myocardial Dysfunction Through Inflammatory Signaling and Apoptotic Induction

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.

BDNF corrects NLRP3 inflammasome-induced pyroptosis and glucose metabolism reprogramming through KLF2/HK1 pathway in vascular endothelial cells

NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction

Activation of NLRP3 Inflammasomes Contributes to Hyperhomocysteinemia-Aggravated Inflammation and Atherosclerosis in Apoe-Deficient Mice.

Endothelial NLRP3 Inflammasome Activation and Arterial Neointima Formation Associated with Acid Sphingomyelinase During Hypercholesterolemia.

NLRP3 inflammasome role in the occurrence and development of atherosclerosis

High glucose levels accelerate atherosclerosis via NLRP3-IL/ MAPK/NF-κB-related inflammation pathways

GP73 enhances the ox-LDL-induced inflammatory response in THP-1 derived macrophages via affecting NLRP3 inflammasome signaling

Abstract 461: Enhanced Glycolysis in Endothelial Cells Protects Against Atherosclerosis

NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies

Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin.

Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis

Interactions Between PCSK9 and NLRP3 Inflammasome Signaling in Atherosclerosis